Intervening Factors for the Initiation of Treatment of Patients with Stomach and Colorectal Cancer

Overview

Journal Rev Lat Am Enfermagem

Specialty Nursing

Date 2017 May 18

PMID 28513766

Authors

Thaina Dalla Valle

Ruth Natalia Teresa Turrini

Vanessa de Brito Poveda

Affiliations

Soon will be listed here.

Abstract

Objective: to identify the time between symptoms, the request for care and the beginning of treatment in patients with stomach and colorectal cancer as well as the factors that interfere in these processes.

Method: correlational descriptive study, including 101 patients diagnosed with stomach or colorectal cancer, treated in a hospital specialized in oncology.

Results: the 101 patients investigated there was predominance of males, mean age of 61.7 years. The search for medical care occurred within 30 days after the onset of symptoms, in most cases. The mean total time between the onset of symptoms and the beginning of treatment ranged from 15 to 16 months, and the mean time between the search for medical care and the diagnosis was 4.78 months. The family history of cancer (p=0.008) and the implementation of preventive follow-up (p<0.001) were associated with shorter periods between the search for care and the beginning of treatment. Nausea, vomiting, hematochezia, weight loss and pain were associated with faster demand for care.

Conclusion: the longer interval between the search for medical care and the diagnosis was possibly due to the non-association between the presented symptoms and the disease.

Citing Articles

Access to healthcare: waiting time until the surgical procedure.

Lemos C, Magalhaes A, Saraiva Tuma Dos Reis D, de Andrade A, de Almeida K, Zerbieri Martins F Ann Med. 2025; 57(1):2452358.

PMID: 39829371 PMC: 11749150. DOI: 10.1080/07853890.2025.2452358.

References

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

Walter V, Jansen L, Ulrich A, Roth W, Blaker H, Chang-Claude J . Alcohol consumption and survival of colorectal cancer patients: a population-based study from Germany. Am J Clin Nutr. 2016; 103(6):1497-506. DOI: 10.3945/ajcn.115.127092. View

Walter F, Emery J, Mendonca S, Hall N, Morris H, Mills K . Symptoms and patient factors associated with longer time to diagnosis for colorectal cancer: results from a prospective cohort study. Br J Cancer. 2016; 115(5):533-41. PMC: 4997546. DOI: 10.1038/bjc.2016.221. View

Khong T, Naik K, Sivakumar R, Shah S . Impact of the United Kingdom national bowel cancer awareness campaigns 2012 on colorectal cancer services and patient survival. Colorectal Dis. 2015; 17(12):1055-61. DOI: 10.1111/codi.13038. View

Hatch Q, Kniery K, Johnson E, Flores S, Moeil D, Thompson J . Screening or Symptoms? How Do We Detect Colorectal Cancer in an Equal Access Health Care System?. J Gastrointest Surg. 2015; 20(2):431-8. DOI: 10.1007/s11605-015-3042-6. View

Aran V, Victorino A, Thuler L, Ferreira C . Colorectal Cancer: Epidemiology, Disease Mechanisms and Interventions to Reduce Onset and Mortality. Clin Colorectal Cancer. 2016; 15(3):195-203. DOI: 10.1016/j.clcc.2016.02.008. View

Siegel R, DeSantis C, Jemal A . Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014; 64(2):104-17. DOI: 10.3322/caac.21220. View

Vega P, Valentin F, Cubiella J . Colorectal cancer diagnosis: Pitfalls and opportunities. World J Gastrointest Oncol. 2015; 7(12):422-33. PMC: 4678389. DOI: 10.4251/wjgo.v7.i12.422. View

Welch H, Robertson D . Colorectal Cancer on the Decline--Why Screening Can't Explain It All. N Engl J Med. 2016; 374(17):1605-7. DOI: 10.1056/NEJMp1600448. View

10.

Walter V, Jansen L, Hoffmeister M, Ulrich A, Chang-Claude J, Brenner H . Smoking and survival of colorectal cancer patients: population-based study from Germany. Int J Cancer. 2015; 137(6):1433-45. DOI: 10.1002/ijc.29511. View

11.

Karimi P, Islami F, Anandasabapathy S, Freedman N, Kamangar F . Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014; 23(5):700-13. PMC: 4019373. DOI: 10.1158/1055-9965.EPI-13-1057. View

12.

Marano L, Polom K, Patriti A, Roviello G, Falco G, Stracqualursi A . Surgical management of advanced gastric cancer: An evolving issue. Eur J Surg Oncol. 2015; 42(1):18-27. DOI: 10.1016/j.ejso.2015.10.016. View

13.

Pereira A, Cesarino C, Martins M, Pinto M, Gomes Netinho J . Associations among socio-demographic and clinical factors and the quality of life of ostomized patients. Rev Lat Am Enfermagem. 2012; 20(1):93-100. DOI: 10.1590/s0104-11692012000100013. View

14.

Ross W . Colorectal cancer screening in evolution: Japan and the USA. J Gastroenterol Hepatol. 2010; 25 Suppl 1:S49-56. DOI: 10.1111/j.1440-1746.2010.06221.x. View

15.

Zarcos-Pedrinaci I, Fernandez-Lopez A, Tellez T, Rivas-Ruiz F, Rueda A, Morales Suarez-Varela M . Factors that influence treatment delay in patients with colorectal cancer. Oncotarget. 2016; 8(22):36728-36742. PMC: 5482692. DOI: 10.18632/oncotarget.13574. View

16.

Zauber A . The impact of screening on colorectal cancer mortality and incidence: has it really made a difference?. Dig Dis Sci. 2015; 60(3):681-91. PMC: 4412262. DOI: 10.1007/s10620-015-3600-5. View

17.

Azevedo E Silva G, Rezende L, Da Silva Gomes F, Souza Junior P, Szwarcwald C, Neto J . Lifestyle among former cancer patients in Brazil in 2013. Cien Saude Colet. 2016; 21(2):379-88. DOI: 10.1590/1413-81232015211.24722015. View

18.

Iversen L . Aspects of survival from colorectal cancer in Denmark. Dan Med J. 2012; 59(4):B4428. View

19.

Esteva M, Leiva A, Ramos M, Pita-Fernandez S, Gonzalez-Lujan L, Casamitjana M . Factors related with symptom duration until diagnosis and treatment of symptomatic colorectal cancer. BMC Cancer. 2013; 13:87. PMC: 3598975. DOI: 10.1186/1471-2407-13-87. View